Young S. Kim
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes.
Journal: Translational lung cancer research
Published: November 26, 2025
Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19).
Journal: Cancer research and treatment
Published: November 18, 2025
A Prognostic Nomogram Combining Radiologic Emphysema and Clinical Parameters in Small Cell Lung Cancer.
Journal: Cancer management and research
Published: September 24, 2025
Utilization, Reimbursement, and Barriers to Accessing Sequencing Tests for Cancer Care in the Asia-Pacific Region: KSMO Initiatives to Address Cancer Care Inequity.
Journal: Cancer research and treatment
Published: August 20, 2025
Efficacy and Safety of a 3-Weekly TS-1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study.
Journal: Cancer medicine
Published: October 11, 2024
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).
Journal: Cancer
Published: August 09, 2024
Significant Dissatisfaction with an Outdated System: A Survey on the Experience of Application for Off-Label Use of Anti-cancer Drugs by the Korean Society of Medical Oncology.
Journal: Cancer research and treatment
Published: August 07, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18.
Journal: JTO clinical and research reports
Published: March 31, 2024
Real-world treatment outcomes in South Korean patients with epidermal growth factor receptor-mutant non-small cell lung cancer.
Journal: The Korean journal of internal medicine
Published: February 12, 2024
Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
Journal: Gynecologic oncology
Published: October 24, 2023
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 19, 2022
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis.
Journal: American journal of clinical oncology
Published: January 06, 2022
Last Updated: 09/26/2026